ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Lonza to Divest Specialty Ingredients Biz contractpharma
February 10, 2021Lonza has entered into a definitive agreement with Bain Capital and Cinven to to sell its Specialty Ingredients business and operations for an enterprise value of CHF 4.2 billion.
Pharma Sources Insight January 2025
